ARTICLE | Company News
Bioglan and CeNeS in pain collaboration
February 1, 2000 8:00 AM UTC
The companies will develop an aerosol form of an opioid analgesic to treat severe pain, such as breakthrough cancer pain and pain after surgery. CeNeS (LSE:CEN) will have exclusive rights to the produ...